Loading clinical trials...

RECRUITINGPhase 2NCT03581773

Folic Acid Supplement Versus Placebo for Treating Mucositis Adverse Events in Metastatic Renal Cell Carcinoma Patients Receiving Targeted Therapy

FASTERCC: Folic acid supplement versus placebo for treating mucositis adverse events in metastatic renal cell carcinoma patients receiving targeted therapy. A randomized, double-blind trial from the D...

Lead sponsor: Niels Fristrup•2 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Contacts

Niels Fristrup, MD PhD

CONTACT

004520914161 niels.fristrup@rm.dk

Related studies

RECRUITINGPhase 2

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

NCT06532279 · Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, and more

RECRUITINGPhase 2

Traditional Chinese Medicine Oral Liquids and Mouthwashes for Radiation-induced Oral Mucositis in Head and Neck Cancer Patients

NCT07282483 · Radiation-induced Oral Mucositis

RECRUITINGPhase 2

Traditional Chinese Medicine Preparation Alleviates Radiotherapy-induced Oral Mucositis in Head and Neck Cancer Patients.

NCT07339774 · Radiotherapy-induced Oral Mucositis

RECRUITINGNA

Prevention of Oral Mucositis in Head and Neck Cancer.

NCT05853692 · Oral Mucositis

RECRUITINGNA

Impact of Keratinized Mucosa Augmentation on Treatment Outcomes of Peri-implant Mucositis

NCT06305000 · Peri-implant Mucositis

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 5, 2025Terms

Trial snapshot

StatusRECRUITING

PhasePHASE2

Enrollment100

Start dateDec 2017

Last updatedMar 5, 2025

Condition

Mucositis Stomatitis

Locations shown

Aarhus University Hospital, Department of oncology

Aarhus, Central Region of Denmark

Department of Oncology, Herlev Hospital

Herlev

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 5, 2025Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Folic Acid Supplement Versus Placebo for Treating Mucositis Adverse Events in Metastatic Renal Cell Carcinoma Patients Receiving Targeted Therapy

What this study is about

Clareo turns complex medical information into clear understanding you can use.

Contacts

Sponsors

Related studies

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

Traditional Chinese Medicine Oral Liquids and Mouthwashes for Radiation-induced Oral Mucositis in Head and Neck Cancer Patients

Traditional Chinese Medicine Preparation Alleviates Radiotherapy-induced Oral Mucositis in Head and Neck Cancer Patients.

Prevention of Oral Mucositis in Head and Neck Cancer.

Impact of Keratinized Mucosa Augmentation on Treatment Outcomes of Peri-implant Mucositis

Trial snapshot

Condition

Locations shown

For caregivers